Study
Roles of autophagy in brain homeostasis and disease
A Nature Neuroscience review maps how autophagy and lysosome pathways support neuronal homeostasis across age and how their disruption contributes to neurological disease.
Summary Does the brain’s recycling system help prevent aging and disease? Show / hide ↓
Researchers reviewed studies of autophagy, the cell’s recycling system, in the brain. This system sends worn-out proteins and cell parts to lysosomes, tiny compartments that break them down so materials can be reused. They examined evidence from people with inherited disorders, laboratory animals, and cells involving neurons, or nerve cells, and glial cells, or support cells. Faulty recycling is linked to brain development problems, memory and movement diseases, and some psychiatric conditions. The review did not test a treatment or enroll participants.
What this means for you: This supports the idea that brain cell recycling matters, but it does not show that fasting, rapamycin, spermidine, or supplements prevent brain disease or extend human life. Ignore products making those claims unless human trials support them.
early evidenceHenry Kim and colleagues review autophagy in developing and mature neurons and glial cells. They describe macroautophagy as a lysosome-dependent recycling system that removes proteins and organelles and returns their components to the cell. Genetic variants in autophagy genes cause human Mendelian disorders that primarily affect the nervous system. The review connects altered autophagy-lysosome activity with neurodevelopmental disorders, neurodegeneration, and psychiatric conditions. It also discusses age-dependent changes in neuronal quality control and the interaction of autophagy with membrane-trafficking pathways. The translational focus is biomarker discovery and therapeutic targeting of autophagy-lysosome pathways. This is not a clinical trial and it does not establish that fasting, rapamycin, spermidine, or another autophagy-modulating intervention improves human longevity. Its value is mechanistic: it organizes evidence linking cellular recycling to brain maintenance and identifies intervention points that require clinical testing.
Recent insights into the dysregulation of autophagy provide valuable avenues for biomarker identification and therapeutic development, particularly targeting autophagy-lysosome pathways for neurological disorders.
Review article. It synthesizes mechanistic and disease evidence but provides no new intervention result or proof of a longevity benefit in humans.
Cited by
2 encyclopedia entries reference this study.